International, Peer Reviewed, Open Access Journal

Annals of Hematology and Oncology Research
(ISSN: 2692-7950)

Submit Manuscript

Annals of Hematology and Oncology Research

Annals of Hematology and Oncology Research (ISSN: 2692-7950) is a peer- reviewed, open access, international journal published by Medtext Publications. This journal covers clinical and experimental work which includes Hematology, Oncology, hemostaseology, blood transfusion and other related aspects including molecular biology, blood diseases, Epidemiology, Etiology, Diagnosis, Prognosis, Management and Treatment.

Journal Features

Open Access

All the articles will be published under Open Access model.

Peer Review

Our editorial team performs strict peer-review process.

Publication Ethics

The journal follows standard guidelines to maintain transparency.

Submit Manuscript

The journal accepts all original articles, reviews and more.

About the Journal

Annals of Hematology and Oncology Research (ISSN: 2692-7950) is a peer- reviewed, open access, international journal published by Medtext Publications. This journal covers clinical and experimental work which includes Hematology, Oncology, hemostaseology, blood transfusion and other related aspects including molecular biology, blood diseases, Epidemiology, Etiology, Diagnosis, Prognosis, Management and Treatment. Medtext Publications is one of the prestigious and leading publishing house and providing an platform for our researchers, scientists, academicians, clinicians and other expertise in the field of science to publish their work and its reaches globally by making the manuscript available on the internet and the people can study it, gain knowledge from it without subscribing and can visit infinite time. Annals of Hematology and Oncology Research accepts Original article, Review article, Case reports, Case series, Editorial, Perspectives, Short Communications, Surgical techniques on all related work of hematology and oncology. To maintain the quality and standard of the journal, we invite expertise to become a part of our journal as an Editorial Member and provide their guidance which aid in the journal growth and also by contributing their work.

Open Access - Annals of Hematology and Oncology Research

Editorial Board

Reza Rastmanesh - Annals of Hematology and Oncology Research

Reza Rastmanesh

Researcher
United States

Alireza Heidari - Annals of Hematology and Oncology Research

Alireza Heidari

California South University
United States

James J. Driscoll - Annals of Hematology and Oncology Research

James J. Driscoll

University of Cincinnati College of Medicine
United States

Al-Ola Abdallah - Annals of Hematology and Oncology Research

Al-Ola Abdallah

University of Kansas Medical CenterĀ 
United States

Shuangnian Xu - Annals of Hematology and Oncology Research

Shuangnian Xu

Third Military Medical University
China

Maria Moschovi  - Annals of Hematology and Oncology Research

Maria Moschovi

National and Kapodistrian University of Athens
Greece

Anil Tombak - Annals of Hematology and Oncology Research

Anil Tombak

Mersin University
Turkey

Said Yusuf Ahmed Mohamed - Annals of Hematology and Oncology Research

Said Yusuf Ahmed Mohamed

Ain Shams University
Egypt

Hassan Ashktorab - Annals of Hematology and Oncology Research

Hassan Ashktorab

Howard University
United States

Edwin Choy - Annals of Hematology and Oncology Research

Edwin Choy

Harvard Medical School
United States

Mark Joseph Fesler - Annals of Hematology and Oncology Research

Mark Joseph Fesler

Saint Louis University
United States

Jing Yang - Annals of Hematology and Oncology Research

Jing Yang

The University of Texas MD Anderson Cancer Center
United States

Articles

Ann Hematol Oncol Res. 2022;2(1):AHOR-1013 | Open Access

STATs Inhibitors in Cancer Therapy Strategies

Shiva Porvahdani, Behzad Baradaran, Mahdi Talebi, Sina Khodakarimi, Hannaneh Bakhshi Miyandoab, Tohid Kazemi, Dariush Shanehbandi, Zohre Yaaghoubi, Ali Akbar Movassaghpour Akbari

REVIEW ARTICLE Updated Aug 24, 2022   PDF

Ann Hematol Oncol Res. 2022;2(1):AHOR-02-1012 | Open Access

Busulfan, Etoposide and Cyclophosphamide versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma

Kimambo EH, Li LH, Ma DD, Ling Y, Miao WJ, Li WF and Ji XB

RESEARCH ARTICLE Updated Mar 14, 2022   PDF

Ann Hematol Oncol Res. 2021;2(1):AHOR-1011 | Open Access

Optimal Management of Haemarthrosis in Patients with Haemophilia in Emergency Room

López-Arroyo José Luis

RESEARCH ARTICLE Updated Jul 08, 2021   PDF

Ann Hematol Oncol Res. 2021;2(1):AHOR-1010 | Open Access

Massive Bone Marrow Carcinomatosis Presenting with Leukoerythroblastic Blood Reaction

A. Garzó, J Verdú-Belmar, E Campos, FJ De Paz and F Tarín

IMAGE ARTICLE Updated Apr 30, 2021   PDF

Ann Hematol Oncol Res. 2020;1(2):AHOR-01-1009 | Open Access

Smartphone: A New Tool for Precisely Locating the Posterior Iliac Crest to Obtain Bone Marrow Aspiration and Trephine (Core) Biopsies

Anwarul Islam

RESEARCH ARTICLE Updated Oct 15, 2020   PDF